PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 11, 2026Asian Pacific Journal of Cancer Prevention1 citationsOpen Access

Profiles of microRNAs in Patients with Advanced Breast Cancer Who are Chemoresistant or Chemosensitive to Fluorouracil, Adriamycin, and Cyclophosphamide Treatment

ETEneida Turiján-EspinozaUniversidad de GuadalajaraVRVictor Manuel Ruiz-RodríguezAutonomous University of San Luis PotosíVPVíctor Alejandro Paz-RodríguezAutonomous University of San Luis Potosí

Key Points

  • The aim is to explore the role of microRNAs as biomarkers in identifying breast cancer patients who respond differently to treatment.
  • Analyzed microRNA profiles in breast cancer patients
  • Grouped patients based on chemosensitivity to fluorouracil, adriamycin, and cyclophosphamide
  • Identified potential predictive biomarkers and therapeutic targets
  • Certain microRNAs were associated with chemoresistance or chemosensitivity
  • MicroRNAs may provide insight into personalized treatment strategies
  • Findings suggest that microRNAs could be monitored for treatment responses

Abstract

Therefore, these findings suggest that miRNAs may serve as predictive biomarkers and potential therapeutic targets in the management of breast cancer.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Turiján-Espinoza et al. (2026) studied this question.

synapsesocial.com/papers/698c1bb8267fb587c655da8ahttps://doi.org/10.31557/apjcp.2026.27.2.469
Ask AI
Helpful
Bookmark
Share
View Full Paper